KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Cash from Investing Activities (2016 - 2025)

Petmed Express' Cash from Investing Activities history spans 16 years, with the latest figure at $21000.0 for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 102.7% year-over-year to $21000.0; the TTM value through Dec 2025 reached -$6.3 million, down 58.02%, while the annual FY2025 figure was -$5.1 million, 87.43% up from the prior year.
  • Cash from Investing Activities reached $21000.0 in Q4 2025 per PETS's latest filing, up from -$2.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $21000.0 in Q4 2025 to a low of -$37.0 million in Q2 2023.
  • Average Cash from Investing Activities over 5 years is -$3.1 million, with a median of -$1.1 million recorded in 2022.
  • Peak YoY movement for Cash from Investing Activities: crashed 1154.09% in 2022, then surged 102.7% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$294000.0 in 2021, then tumbled by 237.76% to -$993000.0 in 2022, then crashed by 43.3% to -$1.4 million in 2023, then soared by 45.4% to -$777000.0 in 2024, then surged by 102.7% to $21000.0 in 2025.
  • Per Business Quant, the three most recent readings for PETS's Cash from Investing Activities are $21000.0 (Q4 2025), -$2.6 million (Q3 2025), and -$1.3 million (Q2 2025).